IRIS

Sfoglia per Rivista  LEUKEMIA

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 5 a 24 di 39
Titolo Data di pubblicazione Autore(i) File
BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts 1-gen-2014 Locatelli, S. L.; Cleris, L.; Stirparo, G.; Tartari, S.; Saba, E.; Pierdominici, M.; Malorni, W.; Carbone, A.; Anichini, A.; Carlo-Stella, C.
Biologic and phenotypic analysis of early hematopoietic progenitor cells in umbilical cord blood 1-gen-1997 Almici, C; Carlo-Stella, C.; Wagner, Je; Mangoni, L; Garau, D; Rizzoli, V
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis. 1-gen-2004 Cuneo, A; Rigolin, Gm; Bigoni, R; De Angeli, C; Veronese, A; Cavazzini, F; Bardi, A; Roberti, Mg; Tammiso, E; Agostini, P; Ciccone, M; Tieghi, A; Cavazzini, L; Negrini, M; Castoldi, G.; DELLA PORTA, MATTEO GIOVANNI
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype. 1-gen-2001 Rigolin, Gm; Bigoni, R; Milani, R; Cavazzini, F; Roberti, Mg; Bardi, A; Agostini, P; Tieghi, A; Piva, N; Cuneo, A; Castoldi, G.; DELLA PORTA, MATTEO GIOVANNI
Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome 1-gen-2019 Todisco, Gabriele
Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2 P95-mutated neoplasms 1-gen-2021 Todisco, Gabriele
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised international prognostic scoring system (IPSS-R) 1-gen-2017 Della Porta, M; Jackson, Ch; Alessandrino, Ep; Rossi, M; Bacigalupo, A; van Lint, Mt; Bernardi, M; Allione, B; Bosi, A; Guidi, S; Santini, V; Malcovati, L; Ubezio, M; Milanesi, C; Todisco, E; Voso, Mt; Musto, P; Onida, F; Iori, Ap; Cerretti, R; Grillo, G; Molteni, A; Pioltelli, P; Borin, L; Angelucci, E; Oldani, E; Sica, S; Pascutto, C; Ferretti, V; Santoro, A; Bonifazi, F; Cazzola, M; Rambaldi, A.
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. 1-gen-2010 DELLA PORTA, MATTEO GIOVANNI
Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts 1-gen-2003 Lunghi, P.; Tabilio, A.; Dall'Aglio, P. P.; Ridolo, E.; Carlo-Stella, C.; Pelicci, P. G.; Bonati, A.
EFFECTS OF DESFERRIOXAMINE ON NORMAL AND LEUKEMIC HUMAN HEMATOPOIETIC-CELL GROWTH - INVITRO AND INVIVO STUDIES 1-gen-1989 Dezza, L; Cazzola, M; Danova, M; CARLO STELLA, C.; Bergamaschi, G; Brugnatelli, S; Invernizzi, R; Mazzini, G; Riccardi, A; Ascari, E
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes 1-gen-2022 Zeidan, Amer M; Bewersdorf, Jan Philipp; Buckstein, Rena; Sekeres, Mikkael A; Steensma, David P; Platzbecker, Uwe; Loghavi, Sanam; Boultwood, Jacqueline; Bejar, Rafael; Bennett, John M; Borate, Uma; Brunner, Andrew M; Carraway, Hetty; Churpek, Jane E; Daver, Naval G; Della Porta, Matteo; Dezern, Amy E; Efficace, Fabio; Fenaux, Pierre; Figueroa, Maria E; Greenberg, Peter; Griffiths, Elizabeth A; Halene, Stephanie; Hasserjian, Robert P; Hourigan, Christopher S; Kim, Nina; Kim, Tae Kon; Komrokji, Rami S; Kutchroo, Vijay; List, Alan F; Little, Richard F; Majeti, Ravi; Nazha, Aziz; Nimer, Stephen D; Odenike, Olatoyosi; Padron, Eric; Patnaik, Mrinal M; Roboz, Gail J; Sallman, David A; Sanz, Guillermo; Stahl, Maximilian; Starczynowski, Daniel T; Taylor, Justin; Xie, Zhuoer; Xu, Mina; Savona, Michael R; Wei, Andrew H; Abdel-Wahab, Omar; Santini, Valeria
Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome 1-gen-2005 DELLA PORTA, MATTEO GIOVANNI
Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. 1-gen-2006 DELLA PORTA, MATTEO GIOVANNI
Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia. 1-gen-2010 DELLA PORTA, MATTEO GIOVANNI
GROWTH OF CD34+ ACUTE MYELOBLASTIC-LEUKEMIA COLONY-FORMING CELLS IN RESPONSE TO RECOMBINANT HEMATOPOIETIC GROWTH-FACTORS 1-gen-1990 CARLO-STELLA, C.; Mangoni, L; Almici, C; Frassoni, F; Fiers, W; Rizzoli, V
GROWTH OF HUMAN HEMATOPOIETIC COLONIES FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES IN RESPONSE TO RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR 1-gen-1989 CARLO STELLA, C.; Cazzola, M; Bergamaschi, G; Bernasconi, P; Dezza, L; Invernizzi, R; Pedrazzoli, P
Harmonemia: a universal strategy for flow cytometry immunophenotyping-A European LeukemiaNet WP10 study 1-gen-2016 Lacombe, F; Bernal, E; Bloxham, D; Couzens, S; Della Porta, M; Johansson, U; Kern, W; Macey, M; Matthes, T; Morilla, R; Paiva, A; Palacio, C; Preijers, F; Ratei, R; Siitonen, S; Allou, K; Porwit, A; Béné, Mc
Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes. 1-gen-2008 DELLA PORTA, MATTEO GIOVANNI
Inflammation and multiple myeloma: the Toll connection. 1-gen-2006 Mantovani, A; Garlanda, C
Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF 1-gen-2005 Ricca, I.; Compagno, M.; Ladetto, M.; Rocci, A.; Dell'Aquila, M.; Omedè, P.; De Marco, F.; D'Antico, S.; Caracciolo, D.; Ferrero, D.; Carlo-Stella, C.; Tarella, C.
Mostrati risultati da 5 a 24 di 39
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile